Gene · 5873
Papers3,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of exosomes in ankylosing spondylitis: from biological features and functional cargo to clinical applications. | Front Mol Biosci | 2026 | 41777666 | PubTator, text mining | PubMed |
| Small Extracellular Vesicles in Gestational Diabetes Mellitus: Current Landscape and Emerging Diagnostic Horizons. | J Extracell Biol | 2026 | 41777569 | PubTator, text mining | PubMed |
| Red Blood Cell-Derived Extracellular Vesicles for Gene and RNA Therapeutics: Biological, Engineering, and Translational Challenges. | Int J Nanomedicine | 2026 | 41757335 | PubTator, text mining | PubMed |
| Acid sphingomyelinase inhibition restores RPE homeostasis and photoreceptor function in preclinical Stargardt macular degeneration models. | bioRxiv | 2026 | 41757049 | PubTator, text mining | PubMed |
| Postnatal conversion of methylcytosine to hydroxymethylcytosine reconfigures the human neuronal epigenome. | bioRxiv | 2026 | 41757014 | PubTator, text mining | PubMed |
| Exosome-Mediated Intercellular Communication in the Pathological Processes of Gouty Arthritis and Its Treatment. | Int J Mol Sci | 2026 | 41751795 | PubTator, text mining | PubMed |
| Metabolic Messengers: Extracellular Vesicles as Central Mediators of Metabolic Reprogramming in Renal Cell Cancer. | Biomedicines | 2026 | 41751181 | PubTator, text mining | PubMed |
| Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope. | Cells | 2026 | 41744781 | PubTator, text mining | PubMed |
| Clinical Spectrum of Cutaneous, Ocular, and Hair Manifestations in Patients With Inborn Errors of Immunity: Insights From a Single Center in Turkey. | Immun Inflamm Dis | 2026 | 41738375 | PubTator, text mining | PubMed |
| Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade. | J Natl Cancer Cent | 2026 | 41738042 | PubTator, text mining | PubMed |
| Long non-coding RNAs in the exosomal network: dual roles and clinical implications in cancer. | Anim Cells Syst (Seoul) | 2026 | 41737608 | PubTator, text mining | PubMed |
| Central nervous system involvement in pediatric hemophagocytic lymphohistiocytosis: A single-center descriptive study of clinical features, neurodiagnostic findings, and outcomes. | Clin Hematol Int | 2026 | 41726770 | PubTator, text mining | PubMed |
| Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer. | Signal Transduct Target Ther | 2026 | 41724757 | PubTator, text mining | PubMed |
| Mechanisms of resistance to bruton's tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways. | Ann Hematol | 2026 | 41721839 | PubTator, text mining | PubMed |
| Rab27a Deficiency Mitigates Mitochondrial Damage by Upregulating PPAR-γ in Sepsis Associated Acute Kidney Injury. | FASEB J | 2026 | 41674406 | PubTator, text mining | PubMed |
| Lys-ing the Resistance: Targeting Lysosomes to Overcome Chemoresistance in Ovarian Cancer. | Curr Oncol Rep | 2026 | 41642562 | PubTator, text mining | PubMed |
| Metastatic organotropism in peritoneal metastasis: Paget's hypothesis revisited. | Clin Exp Med | 2026 | 41609906 | PubTator, text mining | PubMed |
| Research Progress of Exosome-Derived microRNA in Alcohol Use Disorders: A Critical Review. | Addict Biol | 2026 | 41603274 | PubTator, text mining | PubMed |
| Does extracellular vesicle specificity truly exist? | Cell Commun Signal | 2026 | 41593667 | PubTator, text mining | PubMed |
| Stratifying high-risk prediabetes clusters using blood-based epigenetic markers. | Biomark Res | 2026 | 41547928 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5873/papers?page=3